Yang S, Zhao L, Mi Y, He W, et al. Effects of sodium-glucose cotransporter 2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: a systematic review and Diabetes Obes Metab 2022 Jun 16. doi: 10.1111/dom.14801.
PMID: 35712807